RGEN Q4 2023 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$156M-16.6% YoY

Gross Profit

$68M43.4% margin

Operating Income

-$887,000-0.6% margin

Net Income

-$25M-16.4% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+10.3%

Cash Flow

Operating Cash Flow

$29M

Free Cash Flow

$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.8B

Total Liabilities

$866M

Stockholders' Equity

$2.0B

Cash & Equivalents

$751M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$156M	$187M	-16.6%
Gross Profit	$68M	$96M	-29.6%
Operating Income	-$887,000	$49M	-101.8%
Net Income	-$25M	$49M	-152.3%

Revenue Segments

Product

$155M100%